Differential regulation of autophagy and cell viability by ceramide species

References

• Racanelli AC, Rothbart SB, Heyer CL, Moran RG. Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer Res. 2009; 69: 5467-74; PMID:19549896; http://dx.doi.org/10.1158/0008-5472.CAN-08-4979
   PubMed Web of Science ®Google Scholar
• Rothbart SB, Racanelli AC, Moran RG. Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas. Cancer Res. 2010; 70: 10299-10309; PMID:21159649; http://dx.doi.org/10.1158/0008-5472.CAN-10-1873
   PubMed Web of Science ®Google Scholar
• Jarmuła A. Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs. Mini Rev Med Chem. 2010; 13: 1211-22; http://dx.doi.org/10.2174/13895575110091211
   Google Scholar
• Fleeman N, Bagust A, McLeod C, Greenhalgh J, Boland A, Dundar Y, Dickson R, Tudur Smith C, Davis H, Green J, et al. Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer. Health Technol Assess. 2010; 14 S1:47-53
   Web of Science ®Google Scholar
• Paglin S, Lee NY, Nakar C, Fitzgerald M, Plotkin J, Deuel B, Hackett N, McMahill M, Sphicas E, Lampen N, et al. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res. 2005; 65:11061-70; PMID:16322256; http://dx.doi.org/10.1158/0008-5472.CAN-05-1083
   PubMed Web of Science ®Google Scholar
• Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eullit P, Hubbard N, Tye G, Burow ME, et al. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Research. 2011; 71: 4955-4967; PMID:21622715; http://dx.doi.org/10.1158/0008-5472.CAN-11-0898
   PubMed Web of Science ®Google Scholar
• Codogno P, Meijer MA. Authophagy and Signaling: Their role in cell survival and cell death. Cell Death and Differentiation. 2005; 12: 1509-1518; PMID:16247498; http://dx.doi.org/10.1038/sj.cdd.4401751
   PubMed Web of Science ®Google Scholar
• Ishdorj G, Li L, Gibson SB. Regulation of autophagy in hematological malignancies: role of reactive oxygen species. Leuk Lymphoma. 2012;53:26-33; PMID:21749305; http://dx.doi.org/10.3109/10428194.2011.604752
   PubMed Web of Science ®Google Scholar
• Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J. 2012;441:523-40; PMID:22187934; http://dx.doi.org/10.1042/BJ20111451
   PubMed Web of Science ®Google Scholar
• Kung CP, Budina A, Balaburski G, Bergenstock MK, Murphy M. Autophagy in tumor suppression and cancer therapy.Crit Rev Eukaryot Gene Expr. 2011;21: 71-100; PMID:21967333; http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v21.i1.50
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature Reviews Drug Discovery 9, 883-897; PMID:21031003; http://dx.doi.org/10.1038/nrd3248
   PubMed Web of Science ®Google Scholar
• Brinkmann, V., Pinschewer D, Chiba K, Feng, L. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol. Sci. 2000; 21, 49-52
   PubMed Web of Science ®Google Scholar
• Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 2003; 554:189-93; http://dx.doi.org/10.1016/S0014-5793(03)01168-2
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002; 277, 21453-21457; PMID:11967257; http://dx.doi.org/10.1074/jbc.C200176200
   PubMed Web of Science ®Google Scholar
• Zemann B, Kinzel B, Müller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, Billich A. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood 2006; 107, 1454-1458; PMID:16223773; http://dx.doi.org/10.1182/blood-2005-07-2628
   PubMed Web of Science ®Google Scholar
• Graler MH, Goetzl EJ. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J. 2004; 18, 551-553; PMID:14715694
   PubMed Web of Science ®Google Scholar
• Liang J, Nagahashi M, Kim EY, Harikumar KB, Yamada A, Huang WC, Hait NC, Allegood JC, Price MM, Avni D, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013; 23:107-20; PMID:23273921; http://dx.doi.org/10.1016/j.ccr.2012.11.013
   PubMed Web of Science ®Google Scholar
• Lahiri S, Park H, Laviad EL, Lu X, Bittman R, Futerman AH. Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner. J Biol Chem. 2009; 284:16090-8; PMID:19357080; http://dx.doi.org/10.1074/jbc.M807438200
   PubMed Web of Science ®Google Scholar
• Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K, Zhang R, Wang H, Yang W, Liu Z. Autophagy induced by FTY720 promotes apoptosis in U266 cells. Eur J Pharm Sci. 2012; 45:600-5; PMID:22281442; http://dx.doi.org/10.1016/j.ejps.2011.12.014
   PubMed Web of Science ®Google Scholar
• Wallington-Beddoe CT, Hewson J, Bradstock KF, Bendall LJ. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy. 2011; 7:707-15; PMID:21460633; http://dx.doi.org/10.4161/auto.7.7.15154
   PubMed Web of Science ®Google Scholar
• Zhang N, Qi Y, Wadham C, Wang L, Warren A, Di W, Xia P. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy. 2010; 6:1157-67; PMID:20935520; http://dx.doi.org/10.4161/auto.6.8.13614
   PubMed Web of Science ®Google Scholar
• Cristobal I, Manso R, Rincon R, Carames C, Senin C, Borrero A, Martinez-Useros J, Rodriguez M, Zazo S, Martinez-Aguilera O, et al. PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential. Mol Cancer Ther. 2014 Apr;13(4):938–47; PMID:24448818; http://dx.doi.org/10.1158/1535-7163.MCT-13-0150
   PubMedGoogle Scholar
• Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL, Chen CS. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res. 2008;68:1204-12; PMID:18281497; http://dx.doi.org/10.1158/0008-5472.CAN-07-2621
   PubMed Web of Science ®Google Scholar
• Ng KT, Man K, Ho JW, Sun CK, Lee TK, Zhao Y, Lo CM, Poon RT, Fan ST. Marked suppression of tumor growth by FTY720 in a rat liver tumor model: the significance of down-regulation of cell survival Akt pathway. Int J Oncol. 2007;30:375-80; PMID:17203219
   PubMed Web of Science ®Google Scholar
• Lee TK, Man K, Ho JW, Sun CK, Ng KT, Wang XH, Wong YC, Ng IO, Xu R, Fan ST. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation. Carcinogenesis. 2004; 25:2397-405; PMID:15297371; http://dx.doi.org/10.1093/carcin/bgh250
   PubMed Web of Science ®Google Scholar
• Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, Gotoh R, Okuyama A, Suzuki S, Katsuoka Y, et al. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl−dependent pathway and impairment in ERK activity. Anticancer Res. 2003;23:3183-93; PMID:12926052
   PubMed Web of Science ®Google Scholar
• Bareford MD, Hamed HA, Allegood J, Cruickshanks N, Poklepovic A, Park MA, Ogretmen B, Spiegel S, Grant S, Dent P. Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer Biol Ther. 2012;13:793-803; PMID:22673740; http://dx.doi.org/10.4161/cbt.20562
   PubMed Web of Science ®Google Scholar
• Yacoub A, Hamed HA, Allegood J, Mitchell C, Spiegel S, Lesniak MS, Ogretmen B, Dash R, Sarkar D, Broaddus WC, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res. 2010;70:1120-9; PMID:20103619; http://dx.doi.org/10.1158/0008-5472.CAN-09-4043
   PubMed Web of Science ®Google Scholar
• Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH, Huang TH, et al. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res. 2006; 66:11954-66; PMID:17178894; http://dx.doi.org/10.1158/0008-5472.CAN-06-1666
   PubMed Web of Science ®Google Scholar
• Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol. 2005;7:164-76; PMID:15831234; http://dx.doi.org/10.1215/S1152851704000821
   PubMed Web of Science ®Google Scholar
• Carón RW, Yacoub A, Li M, Zhu X, Mitchell C, Hong Y, Hawkins W, Sasazuki T, Shirasawa S, Kozikowski AP, et al. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Mol Cancer Ther. 2005;4:257-70; PMID:15713897
   PubMed Web of Science ®Google Scholar
• Carón RW, Yacoub A, Zhu X, Mitchell C, Han SI, Sasazuki T, Shirasawa S, Hagan MP, Grant S, Dent P. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent. Mol Cancer Ther. 2005;4:243-55; PMID:15713896
   PubMed Web of Science ®Google Scholar
• Ihle NT, Lemos R Jr, Wipf P, Yacoub A, Mitchell C, Siwak D, Mills GB, Dent P, Kirkpatrick DL, Powis G. Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance. Cancer Res. 2009;69:143-50; PMID:19117997; http://dx.doi.org/10.1158/0008-5472.CAN-07-6656
   PubMed Web of Science ®Google Scholar
• Price MM, Oskeritzian CA, Falanga YT, Harikumar KB, Allegood JC, Alvarez SE, Conrad D, Ryan JJ, Milstien S, Spiegel S. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. J Allergy Clin Immunol. 2013; 131:501-11; PMID:22939756; http://dx.doi.org/10.1016/j.jaci.2012.07.014
   PubMed Web of Science ®Google Scholar
• Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S, et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res. 2012;72:726-35; PMID:22298596; http://dx.doi.org/10.1158/0008-5472.CAN-11-2167
   PubMed Web of Science ®Google Scholar
• Jiang Q, Rao X, Kim CY, Freiser H, Zhang Q, Jiang Z, Li G. Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide. Int J Cancer. 2012;130:685-93; PMID:21400505; http://dx.doi.org/10.1002/ijc.26054
   PubMed Web of Science ®Google Scholar
• Shinojima N, Yokoyama T, Kondo Y, Kondo S. Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy. 2007;3:635-7; PMID:17786026; http://dx.doi.org/10.4161/auto.4916
   PubMed Web of Science ®Google Scholar
• Li Y, Li S, Qin X, Hou W, Dong H, Yao L, Xiong L. The pleiotropic roles of sphingolipid signaling in autophagy. Cell Death Dis. 2014;5:e1415; http://dx.doi.org/10.1038/cddis.2014.383
   Google Scholar
• Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G. Regulation of autophagy by stress-responsive transcription factors. Semin Cancer Biol. 2013;23:310-22; PMID:23726895; http://dx.doi.org/10.1016/j.semcancer.2013.05.008
   PubMed Web of Science ®Google Scholar
• Hamed HA, Das SK, Sokhi UK, Park MA, Cruickshanks N, Archer K, Ogretmen B, Grant S, Sarkar D, Fisher PB, Dent P. Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells. Cancer Biol Ther. 2013;14:1039-49; PMID:24025359; http://dx.doi.org/10.4161/cbt.26110
   PubMed Web of Science ®Google Scholar
• Park MA, Mitchell C, Zhang G, Yacoub A, Allegood J, Häussinger D, Reinehr R, Larner A, Spiegel S, Fisher PB, et al. Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res. 2010;70:6313-24; PMID:20631069; http://dx.doi.org/10.1158/0008-5472.CAN-10-0999
   PubMed Web of Science ®Google Scholar
• Walker T, Mitchell C, Park MA, Yacoub A, Rahmani M, Häussinger D, Reinehr R, Voelkel-Johnson C, Fisher PB, Grant S, et al. 17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species. Mol Cancer Ther. 2010;9:1378-95; PMID:20442308; http://dx.doi.org/10.1158/1535-7163.MCT-09-1131
   PubMed Web of Science ®Google Scholar
• Saddoughi SA, Gencer S, Peterson YK, Ward KE, Mukhopadhyay A, Oaks J, Bielawski J, Szulc ZM, Thomas RJ, Selvam SP, et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med. 2013;5:105-21; PMID:23180565; http://dx.doi.org/10.1002/emmm.201201283
   PubMed Web of Science ®Google Scholar
• Sentelle RD, Senkal CE, Jiang W, Ponnusamy S, Gencer S, Selvam SP, Ramshesh VK, Peterson YK, Lemasters JJ, Szulc ZM, et al. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol. 2012;8:831-8; PMID:22922758; http://dx.doi.org/10.1038/nchembio.1059
   PubMed Web of Science ®Google Scholar